You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Flurbiprofen - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for flurbiprofen and what is the scope of freedom to operate?

Flurbiprofen is the generic ingredient in four branded drugs marketed by Pharmacia And Upjohn, Ivax Sub Teva Pharms, Natco Pharma, Pliva, Rising, Sun Pharm Inds Inc, Teva, Theragen, Bausch And Lomb, and Allergan, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for flurbiprofen. Six suppliers are listed for this compound.

Summary for flurbiprofen

US Patents:	0
Tradenames:	4
Applicants:	10
NDAs:	11
Drug Master File Entries:	12
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	167
Clinical Trials:	64
Patent Applications:	7,176
Drug Prices:	Drug price trends for flurbiprofen
Drug Sales Revenues:	Drug sales revenues for flurbiprofen
What excipients (inactive ingredients) are in flurbiprofen?	flurbiprofen excipients list
DailyMed Link:	flurbiprofen at DailyMed

Drug Prices for flurbiprofen

See drug prices for flurbiprofen

Drug Sales Revenue Trends for flurbiprofen

See drug sales revenues for flurbiprofen

Recent Clinical Trials for flurbiprofen

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Pfizer	Phase 1
Beijing Tiantan Hospital	N/A
NorthSea Therapeutics B.V.	Phase 1

See all flurbiprofen clinical trials

Pharmacology for flurbiprofen

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors

Medical Subject Heading (MeSH) Categories for flurbiprofen

Analgesics
Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase Inhibitors

US Patents and Regulatory Information for flurbiprofen

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva	FLURBIPROFEN	flurbiprofen	TABLET;ORAL	074405-002	May 24, 1995		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva	FLURBIPROFEN	flurbiprofen	TABLET;ORAL	074405-001	May 24, 1995		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pliva	FLURBIPROFEN	flurbiprofen	TABLET;ORAL	074647-001	Apr 1, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch And Lomb	FLURBIPROFEN SODIUM	flurbiprofen sodium	SOLUTION/DROPS;OPHTHALMIC	074447-001	Jan 4, 1995		RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-002	Oct 31, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva	FLURBIPROFEN	flurbiprofen	TABLET;ORAL	074431-001	May 31, 1995		RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Inds Inc	FLURBIPROFEN	flurbiprofen	TABLET;ORAL	075058-001	Apr 27, 2001		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for flurbiprofen

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-003	Oct 31, 1988	⤷ Sign Up	⤷ Sign Up
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-002	Oct 31, 1988	⤷ Sign Up	⤷ Sign Up
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-003	Oct 31, 1988	⤷ Sign Up	⤷ Sign Up
Pharmacia And Upjohn	ANSAID	flurbiprofen	TABLET;ORAL	018766-002	Oct 31, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.